Scholar Rock, Inc.
Clinical trials sponsored by Scholar Rock, Inc., explained in plain language.
-
New drug shows promise for kids with spinal muscular atrophy
Disease control CompletedThis study tested a new medicine called apitegromab in 188 children (ages 2–21) with later-onset spinal muscular atrophy (SMA types 2 and 3) who were already taking standard treatments. The goal was to see if adding apitegromab could further improve muscle function and movement. …
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 26, 2026 03:08 UTC
-
New drug may help keep muscle while shedding pounds
Disease control CompletedThis study tested a drug called apitegromab in 102 overweight or obese adults who were also taking a GLP-1 weight-loss medication. The goal was to see if apitegromab could help preserve lean body mass (muscle) while losing weight. Participants received either apitegromab or a pla…
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 26, 2026 02:47 UTC